Yen-Ju Chen

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Ankylosing Spondylitis

Peritoneal Dialysis

Systemic Lupus Erythematosus

Ejection Fraction

Top Venues

Therapeutic advances in musculoskeletal disease

This page only lists publications with an associated author ORCID identifier.

Publications

Yen-Ju Chen, Tzu-Hung Hsiao, Ying-Cheng Lin, Wen-Juei Jeng, Chien-Lin Mao, Chia-Yi Wei, Yi-Chung Hsieh, Chih-Jen Huang, Mei-Hung Pan, I-Chieh Chen, Ching-Heng Lin, Yi Ming Chen, Hwai-I Yang
Polygenic Risk Score Predicts Earlier-Onset Adult Systemic Lupus Erythematosus and First-Year Renal Diseases in a Taiwanese Cohort. RMD open 10 (2) (2024)
Yen-Ju Chen, Tzu-Hung Hsiao, Ying-Cheng Lin, Wen-Juei Jeng, Chien-Lin Mao, Chia-Yi Wei, Yi-Chung Hsieh, Chih-Jen Huang, Mei-Hung Pan, I-Chieh Chen, Ching-Heng Lin, Yi Ming Chen, Hwai-I Yang
Polygenic Risk Score Predicts Earlier-Onset Adult Systemic Lupus Erythematosus and First-Year Renal Diseases in a Taiwanese Cohort. RMD open 10 (2) (2024)
Yen-Ju Chen, Tzu-Hung Hsiao, Ying-Cheng Lin, Wen-Juei Jeng, Chien-Lin Mao, Chia-Yi Wei, Yi-Chung Hsieh, Chih-Jen Huang, Mei-Hung Pan, I-Chieh Chen, Ching-Heng Lin, Yi Ming Chen, Hwai-I Yang
Polygenic Risk Score Predicts Earlier-Onset Adult Systemic Lupus Erythematosus and First-Year Renal Diseases in a Taiwanese Cohort. RMD open 10 (2) (2024)
Yen-Ju Chen, Tzu-Hung Hsiao, Ying-Cheng Lin, Wen-Juei Jeng, Chien-Lin Mao, Chia-Yi Wei, Yi-Chung Hsieh, Chih-Jen Huang, Mei-Hung Pan, I-Chieh Chen, Ching-Heng Lin, Yi Ming Chen, Hwai-I Yang
Polygenic Risk Score Predicts Earlier-Onset Adult Systemic Lupus Erythematosus and First-Year Renal Diseases in a Taiwanese Cohort. RMD open 10 (2) (2024)
Yen-Ju Chen, Shih-Chia Liu, Kuo-Lung Lai, Kuo-Tung Tang, Ching-Heng Lin, Yi Ming Chen, Chih-Wei Tseng, Yu-Mei Chang, Donald F Gotcher, Chuang-Chun Chiou, Shao-Jen Weng, Hsin-Hua Chen
Factors associated with risk of major adverse cardiovascular events in patients with rheumatoid arthritis: a nationwide, population-based, case-control study. Therapeutic advances in musculoskeletal disease 13 (2021)